BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Operating Margin (2020 - 2026)

Updated

BridgeBio Pharma's Operating Margin came in at -3.30% for Q3 2026, up 117.00 percentage points from -120.30% a year earlier and up 40.65 percentage points from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Operating Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, BridgeBio Pharma reported Operating Margin of -38.52%, up 133.87 percentage points year-over-year; for FY2025, it came in at -104.25%, up 162.97 percentage points from FY2024.

  • Operating Margin carries a five-year change of +5647.74 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -267.22% in FY2024 (+6261.53 pp), -6528.75% in FY2023 (-5869.11 pp), -659.65% in FY2022 (+167.47 pp) and -827.12% in FY2021 (+4924.88 pp).
  • The Q3 2026 figure represents the highest quarterly Operating Margin since Q1 2024.
  • Year-over-year, Operating Margin has increased for six consecutive quarters, with an average year-over-year change of +3136.27 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q4 2021 (a gain of 103213.96 percentage points), and the weakest in Q3 2022 (a drop of 31822.06 percentage points).
  • Business Quant data shows BBIO's Operating Margin at -43.94% (Q2 2026), -54.47% (Q1 2026) and -90.52% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn -3.30%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -3.30%
Jun 30, 2026 -43.94%
Mar 31, 2026 -54.47%
Dec 31, 2025 -90.52%
Sep 30, 2025 -120.30%
Jun 30, 2025 -121.45%
Mar 31, 2025 -89.49%
Dec 31, 2024 -3,842.69%
Sep 30, 2024 -7,018.67%
Jun 30, 2024 -8,096.82%
Mar 31, 2024 0.16%
Dec 31, 2023 -10,167.11%
Sep 30, 2023 -3,854.61%
Jun 30, 2023 -8,903.05%
Mar 31, 2023 -6,909.26%
Dec 31, 2022 -6,910.80%
Sep 30, 2022 -38,200.00%
Jun 30, 2022 -108.72%
Mar 31, 2022 -10,252.54%
Dec 31, 2021 -1,285.22%
API Access

BridgeBio Pharma Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY